Información exclusiva para el profesional de la salud. Aviso No. 2609082002C00442. No. de Veeva: M-EVT-MX-07-26-0002
Evastel^® (F.F. Solución (Oral)) Reg. No. 409M93 SSA IV. Evastel^® Z (F.F. Oblea) Reg. No. 281M2004 SSA IV. Evastel^®(F.F. Comprimido) Reg. No. 412M93 SSA IV.

1.Sastre J. J Investig Allergol Clin Immunol. 2020;30:156-168.
2.Hurst M, Spencer CM. Ebastine: an update of its use in allergic disorders. Drugs. 2000;59(4):981‑1006.
3.Torgal T, Borkar S, Bhide P, Arondekar A. Formulation development and evaluation of fast dissolving films of ebastine. Int J Curr Pharm Res. 2020;12(5):111-5.
4.Roger A, Fortea J, Mora S, Artés M. Ebastine fast-dissolving tablets versus regular tablets: acceptability and preference in patients with allergic rhinitis. Expert Rev Clin Pharmacol. 2008;1(3):381-9.
5.Goyal V, Gupta A, Gupta O, Lal D, Gill M. Comparative efficacy and safety of ebastine 20 mg, ebastine 10 mg and levocetirizine 5 mg in acute urticaria. Journal of Clinical and Diagnostic Research. 2017; 11(3):WC06-WC09
6.Ratner PH, Hampel F Jr, Van Bavel J, Howland WC III. Int Arch Allergy Immunol. 2004;133:371–379.
7. Kolkhir P, Giménez-Arnau AM, Kulthanan K, Peter J, Metz M, Maurer M. Urticaria. Nat Rev Dis Primers. 2022;8(1):61
8.Ciprandi G. Clinical utility and patient adherence with ebastine for allergic rhinitis. Patient Prefer Adherence. 2010;4:389–95.
9.Rao S, Pai S, Vaidya KA, Shanbhag T. Efficacy, safety and cost effectiveness of levocetirizine and ebastine in allergic rhinitis: a comparative study. International Journal of Basic & Clinical Pharmacology 2018; 7(9):1748-1751.
10.Información para prescribir Evastel® (F.F. Solución (Oral)) Reg.No. 409M93 SSA IV.
11.Información para prescribir Evastel® Z (F.F. Oblea) Reg. No. 281M2004 SSA IV.
12.Información para Prescribir Evastel®(F.F. Comprimido) Reg. No. 412M93 SSA IV.
13.Vieira RJ, Gil-Mata S, Ferreira A, et al. Efficacy and safety of oral antihistamines for allergic rhinitis: network meta-analysis. J Allergy Clin Immunol Pract. 2026.
14.Curto-Barredo L, Silvestre JF, Giménez-Arnau AM. Actualización en el tratamiento de la urticaria crónica. Actas Dermosifiliogr. 2014;105(5):469-482. doi: 10.1016/j.ad.2012.12.019.